News

News

Firehawk Pro™ Coronary Rapamycin Target Eluting Stent System Receives NMPA Approval for Marketing -

MicroPort® has received approval from the Chinese NMPA to market its F...

MicroPort NeuroTech™ Debuts on Main Board of HKEX -

As the Pioneer & Largest Chinese Player in the Neuro-interventional Me...

MicroPort® CRM Receives CE Mark Approval for INVICTA™ Defibrillation Leads -

MicroPort® CRM has recently received CE Mark approval for its INVICTA™...

Endovastec™ Presents Flagship Products at CICE 2022 -

Endovastec™ eld a seminar at the International Congress of Endovascula...

Endovastec™ Reewarm™ PTX DCB PTA Catheter Receives Marketing Approval in Brazil -

Endovastec™ today announced that it has received registration approval...

MicroPort® Participates in CIT 2022 and Hosts Joint Satellite Session -

MicroPort® together with its subsidiaries recently participated in the...

MicroPort® Releases 2-Year Results of Firesorb® Pivotal Trial FUTURE II -

MicroPort® recently released the 2-year clinical follow-up results fro...

MicroPort NeuroTech™ Completes First Implantation of Numen™ Coil Embolization System in the U.S. -

with Support from Rapid Medical as Exclusive Distributor...

MicroPort Argus™ OCT System Officially Launched -

Fourteen of China’s top interventional came together to launch the Mic...

Toumai® Completes the World's Longest-Range 5G Tele-Robotic Surgery -

The Toumai® Laparoscopic Surgical Robot successfully completed two ult...

CardioFlow Medtech’s Strategic Partner, 4C Medical, Releases Global Clinical Data on Early Feasibility Study of AltaValve™ Transcatheter Mitral Valve Replacement at AATS 2022 -

CardioFlow Medtech announced that its strategic partner 4C Medical rec...

CardioFlow Medtech’s VitaFlow Liberty™ Wins Italian A' Design Award -

CardioFlow Medtech has been awarded a Silver A' Design Award for its V...

Hemovent™ Showcases Product Portfolio on 10th EuroELSO congress in London -

Hemovent™ has successfully showcased its product portfolio for the fir...

Hemovent™ Receives MDSAP Certificate for United States and Canada -

Hemovent™ has received a MDSAP certificate from DQS in the United Stat...

MicroPort® MedBot® Announces the Completion of R-One® Vascular Interventional Surgical Robot Registrational Clinical Trial -

As the First to Complete Multi-centered Clinical Trial in China...

MicroPort® Meets Global Industry Experts and Scholars in Paris and Presents Several Products at EuroPCR 2022 -

The EuroPCR 2022 was held in-person for the first time since the COVID...